Aire Advisors LLC trimmed its holdings in shares of Parker-Hannifin Corporation (NYSE:PH – Free Report) by 8.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 318 shares of the industrial products company’s stock after selling 31 shares during the quarter. Aire Advisors LLC’s holdings in Parker-Hannifin were worth $222,000 at the end of the most recent reporting period.
Several other hedge funds have also recently made changes to their positions in the business. Vanguard Group Inc. raised its position in shares of Parker-Hannifin by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 11,023,764 shares of the industrial products company’s stock valued at $6,700,795,000 after buying an additional 168,990 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Parker-Hannifin by 52.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,443,104 shares of the industrial products company’s stock valued at $1,485,042,000 after purchasing an additional 842,262 shares during the last quarter. Wellington Management Group LLP grew its holdings in Parker-Hannifin by 11.6% during the 1st quarter. Wellington Management Group LLP now owns 2,009,250 shares of the industrial products company’s stock valued at $1,221,323,000 after purchasing an additional 208,573 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Parker-Hannifin by 0.7% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,594,347 shares of the industrial products company’s stock valued at $969,124,000 after purchasing an additional 11,815 shares during the last quarter. Finally, Nuveen LLC bought a new position in Parker-Hannifin during the 1st quarter valued at about $933,089,000. 82.44% of the stock is currently owned by hedge funds and other institutional investors.
Parker-Hannifin Price Performance
Shares of PH stock opened at $736.06 on Thursday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.19 and a quick ratio of 0.71. The company has a market capitalization of $93.14 billion, a P/E ratio of 27.14, a P/E/G ratio of 3.04 and a beta of 1.35. The company’s 50-day simple moving average is $750.39 and its two-hundred day simple moving average is $687.48. Parker-Hannifin Corporation has a one year low of $488.45 and a one year high of $779.77.
Parker-Hannifin Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 12th. Stockholders of record on Tuesday, September 2nd were paid a dividend of $1.80 per share. The ex-dividend date was Tuesday, September 2nd. This represents a $7.20 dividend on an annualized basis and a dividend yield of 1.0%. Parker-Hannifin’s dividend payout ratio (DPR) is currently 26.55%.
Insider Activity
In other news, COO Andrew D. Ross sold 4,361 shares of the stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $732.66, for a total transaction of $3,195,130.26. Following the transaction, the chief operating officer directly owned 13,120 shares in the company, valued at approximately $9,612,499.20. This trade represents a 24.95% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Angela R. Ives sold 810 shares of the stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $727.36, for a total transaction of $589,161.60. Following the transaction, the vice president owned 2,798 shares in the company, valued at approximately $2,035,153.28. This represents a 22.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 14,039 shares of company stock valued at $10,356,566. 0.32% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on PH shares. Deutsche Bank Aktiengesellschaft downgraded shares of Parker-Hannifin from a “buy” rating to a “hold” rating and set a $809.00 price target on the stock. in a report on Thursday, September 4th. Barclays upped their price target on shares of Parker-Hannifin from $776.00 to $785.00 and gave the company an “overweight” rating in a report on Wednesday, October 1st. Evercore ISI reiterated an “outperform” rating on shares of Parker-Hannifin in a report on Tuesday, August 19th. Raymond James Financial upped their price target on shares of Parker-Hannifin from $735.00 to $845.00 and gave the company an “outperform” rating in a report on Friday, August 8th. Finally, Wells Fargo & Company upped their price target on shares of Parker-Hannifin from $800.00 to $840.00 and gave the company an “overweight” rating in a report on Monday, October 6th. Fourteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $787.61.
Check Out Our Latest Stock Analysis on Parker-Hannifin
Parker-Hannifin Company Profile
Parker-Hannifin Corporation manufactures and sells motion and control technologies and systems for various mobile, industrial, and aerospace markets worldwide. The company operates through two segments: Diversified Industrial and Aerospace Systems. The Diversified Industrial segment offers sealing, shielding, thermal products and systems, adhesives, coatings, and noise vibration and harshness solutions; filters, systems, and diagnostics solutions to ensure purity and remove contaminants from fuel, air, oil, water, and other liquids and gases; connectors used in fluid and gas handling; and hydraulic, pneumatic, and electromechanical components and systems for builders and users of mobile and industrial machinery and equipment.
Recommended Stories
- Five stocks we like better than Parker-Hannifin
- Short Selling – The Pros and Cons
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What Are Growth Stocks and Investing in Them
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Parker-Hannifin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parker-Hannifin and related companies with MarketBeat.com's FREE daily email newsletter.